DK1515702T6 - Misbrugssikret indgivelsesform - Google Patents
Misbrugssikret indgivelsesform Download PDFInfo
- Publication number
- DK1515702T6 DK1515702T6 DK03735628.4T DK03735628T DK1515702T6 DK 1515702 T6 DK1515702 T6 DK 1515702T6 DK 03735628 T DK03735628 T DK 03735628T DK 1515702 T6 DK1515702 T6 DK 1515702T6
- Authority
- DK
- Denmark
- Prior art keywords
- protected
- abuse
- submission form
- aqueous liquid
- administration form
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10227077 | 2002-06-17 | ||
DE10250083A DE10250083A1 (de) | 2002-06-17 | 2002-10-25 | Gegen Missbrauch gesicherte Darreichungsform |
PCT/EP2003/006314 WO2003105808A1 (de) | 2002-06-17 | 2003-06-16 | Gegen missbrauch gesicherte darreichungsform |
Publications (2)
Publication Number | Publication Date |
---|---|
DK1515702T3 DK1515702T3 (da) | 2009-01-12 |
DK1515702T6 true DK1515702T6 (da) | 2022-04-11 |
Family
ID=29737609
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03735628.4T DK1515702T6 (da) | 2002-06-17 | 2003-06-16 | Misbrugssikret indgivelsesform |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1515702B3 (da) |
JP (2) | JP2005534664A (da) |
AT (1) | ATE411007T1 (da) |
AU (1) | AU2003237944A1 (da) |
CY (1) | CY1108682T1 (da) |
DE (2) | DE10250083A1 (da) |
DK (1) | DK1515702T6 (da) |
ES (1) | ES2315505T7 (da) |
PT (1) | PT1515702E (da) |
SI (1) | SI1515702T1 (da) |
WO (1) | WO2003105808A1 (da) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
DE50309605D1 (de) * | 2002-11-22 | 2008-05-21 | Gruenenthal Gmbh | Verwendung von (1RS,3RS,6RS)-6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexan-1,3-diol zur Behandlung von Entzündungsschmerz |
EP1782834A3 (en) * | 2003-03-13 | 2007-08-01 | Controlled Chemicals, Inc. | Oxycodone conjugates with lower abuse potential and extended duration of action |
DE102005005446A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
US8075872B2 (en) | 2003-08-06 | 2011-12-13 | Gruenenthal Gmbh | Abuse-proofed dosage form |
US20070048228A1 (en) | 2003-08-06 | 2007-03-01 | Elisabeth Arkenau-Maric | Abuse-proofed dosage form |
DE10361596A1 (de) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
DE10336400A1 (de) | 2003-08-06 | 2005-03-24 | Grünenthal GmbH | Gegen Missbrauch gesicherte Darreichungsform |
DE102004032051A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform |
US20050165038A1 (en) * | 2004-01-22 | 2005-07-28 | Maxwell Gordon | Analgetic dosage forms that are resistant to parenteral and inhalation dosing and have reduced side effects |
DE102004019916A1 (de) * | 2004-04-21 | 2005-11-17 | Grünenthal GmbH | Gegen Missbrauch gesichertes wirkstoffhaltiges Pflaster |
AR053304A1 (es) * | 2004-07-01 | 2007-05-02 | Gruenenthal Gmbh | Formas farmaceuticas orales protegidas frente al abuso con liberacion controlada de (1r,2r)-3-(3 dimetilamino-1-etil-2metil-propil)fenol y procedimiento para su produccion. |
FI1765303T4 (fi) * | 2004-07-01 | 2023-01-31 | Väärinkäytöltä suojattu oraalinen tabletti | |
DE102004032103A1 (de) * | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
DE102004032049A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
DE102005005449A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
SA07280459B1 (ar) | 2006-08-25 | 2011-07-20 | بيورديو فارما إل. بي. | أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني |
DE102007011485A1 (de) | 2007-03-07 | 2008-09-11 | Grünenthal GmbH | Darreichungsform mit erschwertem Missbrauch |
US8383152B2 (en) | 2008-01-25 | 2013-02-26 | Gruenenthal Gmbh | Pharmaceutical dosage form |
US9226907B2 (en) | 2008-02-01 | 2016-01-05 | Abbvie Inc. | Extended release hydrocodone acetaminophen and related methods and uses thereof |
HUE030803T2 (en) | 2008-05-09 | 2017-06-28 | Gruenenthal Gmbh | Process for the preparation of an intermediate powder formulation and a final solid dosage form using a spraying step \ t |
CA2766172C (en) | 2009-07-22 | 2017-09-12 | Lutz Barnscheid | Oxidation-stabilized tamper-resistant dosage form |
CA2765971C (en) | 2009-07-22 | 2017-08-22 | Gruenenthal Gmbh | Hot-melt extruded controlled release dosage form |
CZ302789B6 (cs) | 2009-11-25 | 2011-11-09 | Zentiva, K. S. | Zpusob zvýšení rozpustnosti farmaceuticky aktivních látek a cílený (kontrolovaný) transport do streva |
JP5933553B2 (ja) | 2010-09-02 | 2016-06-15 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | アニオン性ポリマーを含む不正使用抵抗性剤形 |
BR112013005194A2 (pt) | 2010-09-02 | 2016-05-03 | Gruenenthal Gmbh | forma de dosagem resistente à violação compreendendo sal inorgânico |
EP2736497B1 (en) | 2011-07-29 | 2017-08-23 | Grünenthal GmbH | Tamper-resistant tablet providing immediate drug release |
PE20141638A1 (es) | 2011-07-29 | 2014-11-22 | Gruenenthal Chemie | Tableta a prueba de manipulacion que proporciona liberacion de farmaco inmediato |
MX356421B (es) | 2012-02-28 | 2018-05-29 | Gruenenthal Gmbh | Forma de dosificacion resistente a la manipulacion indebida que comprende un compuesto farmacologicamente activo y un polimero anionico. |
JP6282261B2 (ja) | 2012-04-18 | 2018-02-21 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 不正使用防止および過量放出防止医薬剤形 |
US10064945B2 (en) | 2012-05-11 | 2018-09-04 | Gruenenthal Gmbh | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc |
MX2015016254A (es) | 2013-05-29 | 2016-04-20 | Gruenenthal Gmbh | Forma de dosificacion resistente al uso indebido con perfil de liberacion bimodal. |
WO2014191397A1 (en) | 2013-05-29 | 2014-12-04 | Grünenthal GmbH | Tamper-resistant dosage form containing one or more particles |
CN105682643B (zh) | 2013-07-12 | 2019-12-13 | 格吕伦塔尔有限公司 | 含有乙烯-醋酸乙烯酯聚合物的防篡改剂型 |
MX371372B (es) | 2013-11-26 | 2020-01-28 | Gruenenthal Gmbh | Preparacion de una composicion farmaceutica en polvo por medio de criomolienda. |
US20150320690A1 (en) | 2014-05-12 | 2015-11-12 | Grünenthal GmbH | Tamper resistant immediate release capsule formulation comprising tapentadol |
WO2015181059A1 (en) | 2014-05-26 | 2015-12-03 | Grünenthal GmbH | Multiparticles safeguarded against ethanolic dose-dumping |
MX2017013637A (es) | 2015-04-24 | 2018-03-08 | Gruenenthal Gmbh | Forma de dosificacion resistente a alteraciones con liberacion inmediata y resistencia contra la extraccion por solventes. |
JP2018526414A (ja) | 2015-09-10 | 2018-09-13 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3980766A (en) * | 1973-08-13 | 1976-09-14 | West Laboratories, Inc. | Orally administered drug composition for therapy in the treatment of narcotic drug addiction |
DE2530563C2 (de) * | 1975-07-09 | 1986-07-24 | Bayer Ag, 5090 Leverkusen | Analgetische Arzneimittel mit vermindertem Mißbrauchspotential |
GB9401894D0 (en) * | 1994-02-01 | 1994-03-30 | Rhone Poulenc Rorer Ltd | New compositions of matter |
KR100417490B1 (ko) * | 1997-12-22 | 2004-02-05 | 유로-셀티크 소시에떼 아노뉨 | 오피오이드 제형의 남용을 방지하는 방법 |
DE20220917U1 (de) * | 2001-08-06 | 2004-08-19 | Euro-Celtique S.A. | Zusammensetzungen zur Verhinderung des Missbrauchs von Opioiden |
MXPA04001208A (es) * | 2001-08-06 | 2004-07-08 | Euro Celtique Sa | Composiciones y metodos para evitar el abuso de los opioides. |
KR20190026065A (ko) | 2010-07-23 | 2019-03-12 | 그뤼넨탈 게엠베하 | 3-(3-디메틸아미노-1-에틸-2-메틸-프로필)-페놀의 염 또는 공결정 |
-
2002
- 2002-10-25 DE DE10250083A patent/DE10250083A1/de not_active Withdrawn
-
2003
- 2003-06-16 AT AT03735628T patent/ATE411007T1/de active
- 2003-06-16 AU AU2003237944A patent/AU2003237944A1/en not_active Abandoned
- 2003-06-16 DE DE50310649T patent/DE50310649D1/de not_active Expired - Lifetime
- 2003-06-16 SI SI200331481T patent/SI1515702T1/sl unknown
- 2003-06-16 DK DK03735628.4T patent/DK1515702T6/da active
- 2003-06-16 ES ES03735628T patent/ES2315505T7/es active Active
- 2003-06-16 EP EP03735628.4A patent/EP1515702B3/de not_active Expired - Lifetime
- 2003-06-16 WO PCT/EP2003/006314 patent/WO2003105808A1/de active Application Filing
- 2003-06-16 PT PT03735628T patent/PT1515702E/pt unknown
- 2003-06-16 JP JP2004512714A patent/JP2005534664A/ja active Pending
-
2008
- 2008-12-30 CY CY20081101510T patent/CY1108682T1/el unknown
-
2011
- 2011-07-15 JP JP2011156717A patent/JP2011251982A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DK1515702T3 (da) | 2009-01-12 |
DE10250083A1 (de) | 2003-12-24 |
ATE411007T1 (de) | 2008-10-15 |
DE50310649D1 (de) | 2008-11-27 |
EP1515702B3 (de) | 2022-01-12 |
EP1515702B1 (de) | 2008-10-15 |
JP2005534664A (ja) | 2005-11-17 |
SI1515702T1 (sl) | 2009-04-30 |
ES2315505T3 (es) | 2009-04-01 |
CY1108682T1 (el) | 2014-04-09 |
AU2003237944A1 (en) | 2003-12-31 |
EP1515702A1 (de) | 2005-03-23 |
ES2315505T7 (es) | 2022-04-07 |
PT1515702E (pt) | 2008-12-29 |
WO2003105808A1 (de) | 2003-12-24 |
JP2011251982A (ja) | 2011-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1515702T6 (da) | Misbrugssikret indgivelsesform | |
SG147485A1 (en) | Pharmaceutical compositions for prevention of overdose or abuse | |
EA200200858A1 (ru) | Фармацевтические композиции, содержащие ингибиторы гликогенфосфорилазы | |
BRPI0410555A (pt) | preparação sólida | |
MXPA06010767A (es) | Composicion farmaceutica anhidra que asocia un agente siliconado y principio activo solubilizado. | |
HRP20020158B1 (en) | Action of synergistic combination | |
BR0214343A (pt) | Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1 | |
UY27465A1 (es) | Métodos y composiciones para tratar flavivirus y pestivirus con 4' modificaciones nucleosides | |
ATE293995T1 (de) | Pharmazeutische zusammensetzungen, die wirkstoffabsorptionsfördernde verbindungen enthalten | |
WO2005017097A3 (en) | Quorum sensing and biofilm formation | |
ATE506959T1 (de) | Verwendung von il-18 inhibitoren | |
DK1327143T3 (da) | Krystalstruktur af BACE og anvendelse deraf | |
NO20035025L (no) | Anvendelse av osteopontin for behandling og/eller for a hindre nevrologiske sykdommer, samt farmasoytisk sammensetning omfattende osteopontin eller en antagonist med osteopontinaktivitet. | |
UY27929A1 (es) | Composiciones farmaceuticas de farmacos semiordenados y polimeros | |
BR0013012A (pt) | Composição contendo substância ativa, sua produção e seu uso | |
EP1354602A4 (en) | MEDICAL COMPOSITIONS WITH DIURETIC AGENT AND IMPROVING INSULIN RESISTANCE | |
NO20020829D0 (no) | Ny anvendelse av docetaxel for behandling av hepatoma | |
ATE297738T1 (de) | Verfahren zur erhöhung der wachsamkeit durch verabreichung von vomeropherin und vomeropherin emittierende alarmvorricthung | |
RS51081B (sr) | Nova sinergistička kombinacija koja uključuje roflumilast i formoterol | |
MA28292A1 (fr) | Forme posologique solide | |
BRPI0516957A (pt) | formulação farmacêutica estabilizada de agente de leucotrieno b4 (ltb4) | |
YU102403A (sh) | Postupci za dizajniranje leka, baziranog na strukturi, za identifikovanje inhibitora d-ala-d-ala ligaze, kao antibakterijskih lekova | |
UY26618A1 (es) | Composiciones farmacéuticas de inhibidores de la gcomposiciones farmacéuticas de inhibidores de la glucógeno-fosforilasa | |
DOP2002000421A (es) | Composiciones farmaceuticas que contienen conjunto de pollimero y farmaco. | |
MA27098A1 (fr) | Composition pharmaceutique orodispersible de piribedil |